AbbVie Inc. (ABBV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for AbbVie Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$285.99
−0.14% today
Market cap
$506.1B
Overall quality
54/100
Kronos AI 30-day
−15.9%
0 of 8 simulated paths end higher
AbbVie Inc. (ABBV) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $506.1B. It trades at $285.99, down 0.14% today, at 80.6 times earnings. Its overall quality score is 54 out of 100, ranked against the whole US market. 24 analysts' average target of $290.48 implies +1.6% from today's price. Kronos AI's 30-day forecast is −15.9% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $290.48 |
| Low – high | $230.00 – $325.00 |
| Analysts | 24 |
| Upside to average | +1.6% |
Kronos AI 30-day forecast
| Expected close | $240.87 (−15.9%) |
| Likely range | −19.8% … −12.9% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 67 |
| Solvency | 52 |
| Growth | 42 |
| Overall | 54 |
| P/E | 80.6 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.